Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality www.ahrq.gov
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Identifying Health Care Quality Measures for Medicaid-Eligible Adults: Background Report

Appendix 4. Public Comment Results (continued)

B. Public Comment Results: Additional Recommended Measures

# Measure Name Owner No. Requests to Add Organizations Requesting

52

Adoption/Use of Medication Electronic Prescribing Measure

CMS

2

Boehringer Ingelheim Pharm
MEDCO/Health Solutions, Inc.

53

Adult BMI Assessment

NCQA

1

American Academy of Family Physicians

54

Appropriate Follow Up for Patients With HIV/AIDS

IMS Health

1

CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention

55

Change in Basic Mobility as Measured by the AM-PAC

CREcare

1

Disability and Rehabilitation Research Coalition

56

Change in Daily Activity Function as Measured by the AM-PAC

CREcare

1

Disability and Rehabilitation Research Coalition

57

Chlamydia Screening in Women

NCQA

1

National Chlamydia Coalition

58

Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy

AMA

1

Boehringer Ingelheim Pharm

59

Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation

AMA

1

Boehringer Ingelheim Pharm

60

Comprehensive Diabetes Care: Eye Exam (Retinal) Performed

NCQA

2

American Academy of Ophthalmology
American Optometric Association

61

Functional Communication Measure—Attention

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

62

Functional Communication Measure—Memory

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

63

Functional Communication Measure—Motor Speech

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

64

Functional Communication Measure —Reading

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

65

Functional Communication Measure—Spoken Language Comprehension

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

66

Functional Communication Measure—Spoken Language Expression

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

67

Functional Communication Measure—Swallowing

American Speech-Language-Hearing Association

 

American Speech-Language-Hearing Association

68

Functional Communication Measure—Writing

American Speech-Language-Hearing Association

1

American Speech-Language-Hearing Association

69

Glaucoma Screening in Older Adults

NCQA

1

American Academy of Ophthalmology

70

HBIPS-3 Hours of Seclusion Use

TJC

1

National Association of Psychiatric Health Systems

71

HBIPS-4 Patients Discharged on Multiple Antipsychotic Medications

TJC

1

National Association of Psychiatric Health Systems

72

HBIPS-5 Patients Discharged on Multiple Antipsychotic Medications With Appropriate Justification

TJC

1

National Association of Psychiatric Health Systems

73

HBIPS-6 Post Discharge Continuing Care Plan Created

TJC

2

Boehringer Ingelheim Pharm
National Association of Psychiatric Health Systems

74

HBIPS-7 Post Discharge Continuing Care Plan Transmitted to Next Level of Care Provider upon Discharge

TJC

1

National Association of Psychiatric Health Systems

75

Health Information Technology (HIT): Adoption/Use of Electronic Health Records (EHR)

CMS

1

Boehringer Ingelheim Pharm

76

Healthy Term Newborn

CMQCC

1

Childbirth Connections

77

Hepatitis C: Antiviral Treatment Prescribed

AMA

1

CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention

78

Hepatitis C: Testing for Chronic Hepatitis C—Confirmation of Hepatitis C Viremia

AMA

2

American Association for the Study of Liver Diseases
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention

79

HIV/AIDS Screening: Members at High Risk of HIV/AIDS

IMS Health

2

CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention
HIV Health Care Access Working Group

80

HIV/AIDS: Adolescent and Adult Patients With HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

AMA, NCQA

1

CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention

81

HIV/AIDS: Hepatitis B Screening

NCQA

1

American Association for the Study of Liver Diseases

82

HIV/AIDS: Tuberculosis (TB) Screening

NCQA

1

CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention

83

Medication Reconciliation Post-Discharge

NCQA

1

Boehringer Ingelheim Pharm

84

Pharmacotherapy of COPD Exacerbation

NCQA

2

Boehringer Ingelheim Pharm
Glaxo SmithKline

85

Reconciled Medication List Received by Discharged Patients (Inpatient Discharges to Home/Self Care or Any Other Site of Care)

AMA

2

Boehringer Ingelheim Pharm
MEDCO/Health Solutions, Inc.

86

Risk-Adjusted Operative Mortality for CABG

The Society of Thoracic Surgeons

1

National Kidney Foundation

87

Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement

The Society of Thoracic Surgeons

1

National Kidney Foundation

88

Risk-Adjusted Operative Mortality for MVR + CABG Surgery

The Society of Thoracic Surgeons

1

National Kidney Foundation

89

Screening Foreign-born Adults for Chronic Hepatitis B

Asian Liver Center at Stanford University

 

American Association for the Study of Liver Diseases

90

Severity-Standardized ALOS—Deliveries

Leapfrog Group

1

MEDCO/Health Solutions, Inc.

91

STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter

TJC

1

Boehringer Ingelheim Pharm

92

Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge

AMA, NCQA

1

Boehringer Ingelheim Pharm

93

Tracking of Clinical Results Between Visits

CMS

1

Childbirth Connection

94

Use of Spirometry Testing in the Assessment and Diagnosis of COPD

NCQA

2

Boehringer Ingelheim Pharm
Glaxo SmithKline

Page last reviewed October 2014
Page originally created December 2010
Internet Citation: Appendix 4. Public Comment Results (continued). Content last reviewed October 2014. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/events/nac/reports/nacqm11/appendix4b.html

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care